Treatment response of lithium augmentation in geriatric compared to non-geriatric patients with treatment-resistant depression.


Journal

Journal of affective disorders
ISSN: 1573-2517
Titre abrégé: J Affect Disord
Pays: Netherlands
ID NLM: 7906073

Informations de publication

Date de publication:
15 05 2019
Historique:
received: 20 12 2018
revised: 09 03 2019
accepted: 19 03 2019
pubmed: 29 3 2019
medline: 13 7 2019
entrez: 29 3 2019
Statut: ppublish

Résumé

Lithium augmentation (LA) of antidepressants is an effective strategy for treatment-resistant depression (TRD). Nevertheless, it is rarely used in geriatric patients. The purpose of this study was to investigate treatment response of LA in geriatric compared to non-geriatric patients. In a prospective multicenter cohort study, severity of depression was measured weekly in 167 patients with unipolar depression (n Geriatric patients showed a significantly better response to LA compared to non-geriatric patients (Hazard Ratio = 1.91; p = 0.04). An important limitation of our study is the lack of a control group of LA and the missing evaluation of side effects in both groups. This is the first study investigating the efficacy of LA for TRD in geriatric compared to non-geriatric patients. Our data suggest that LA is an effective treatment option in geriatric patients that clinicians might consider more frequently and earlier on in the course of treatment.

Sections du résumé

BACKGROUND
Lithium augmentation (LA) of antidepressants is an effective strategy for treatment-resistant depression (TRD). Nevertheless, it is rarely used in geriatric patients. The purpose of this study was to investigate treatment response of LA in geriatric compared to non-geriatric patients.
METHOD
In a prospective multicenter cohort study, severity of depression was measured weekly in 167 patients with unipolar depression (n
RESULTS
Geriatric patients showed a significantly better response to LA compared to non-geriatric patients (Hazard Ratio = 1.91; p = 0.04).
LIMITATIONS
An important limitation of our study is the lack of a control group of LA and the missing evaluation of side effects in both groups.
CONCLUSIONS
This is the first study investigating the efficacy of LA for TRD in geriatric compared to non-geriatric patients. Our data suggest that LA is an effective treatment option in geriatric patients that clinicians might consider more frequently and earlier on in the course of treatment.

Identifiants

pubmed: 30921597
pii: S0165-0327(18)33234-8
doi: 10.1016/j.jad.2019.03.057
pii:
doi:

Substances chimiques

Antidepressive Agents 0
Lithium Carbonate 2BMD2GNA4V

Types de publication

Journal Article Multicenter Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

136-140

Informations de copyright

Copyright © 2019 Elsevier B.V. All rights reserved.

Auteurs

Pichit Buspavanich (P)

Department of Psychiatry, Psychotherapy and Psychosomatics, Brandenburg Medical School Theodor Fontane, Campus Neuruppin, 16816 Germany; Department of Psychiatry and Psychotherapy, Charité Universitätsmedizin Berlin, Campus Mitte, Germany. Electronic address: pichit.buspavanich@charite.de.

Joachim Behr (J)

Department of Psychiatry, Psychotherapy and Psychosomatics, Brandenburg Medical School Theodor Fontane, Campus Neuruppin, 16816 Germany; Research Department of Experimental and Molecular Psychiatry, Department of Psychiatry and Psychotherapy, Charité Universitätsmedizin Berlin, Campus Mitte, Germany.

Thomas Stamm (T)

Department of Psychiatry, Psychotherapy and Psychosomatics, Brandenburg Medical School Theodor Fontane, Campus Neuruppin, 16816 Germany; Department of Psychiatry and Psychotherapy, Charité Universitätsmedizin Berlin, Campus Mitte, Germany.

Peter Schlattmann (P)

Department of Statistics, Informatics and Documentation, Jena University Hospital, Germany.

Tom Bschor (T)

Department of Psychiatry and Psychotherapy, Technical University of Dresden Medical School, Dresden, Germany; Department of Psychiatry, Schlosspark-Klinik Berlin, Germany.

Christoph Richter (C)

Department of Psychiatry and Psychotherapy, Charité Universitätsmedizin Berlin, Campus Mitte, Germany; Department of Psychiatry and Psychotherapy, Vivantes Klinikum Kaulsdorf, Berlin, Germany.

Rainer Hellweg (R)

Department of Psychiatry and Psychotherapy, Charité Universitätsmedizin Berlin, Campus Mitte, Germany.

Andreas Heinz (A)

Department of Psychiatry and Psychotherapy, Charité Universitätsmedizin Berlin, Campus Mitte, Germany.

Maximilian Berger (M)

Department of Psychiatry and Psychotherapy, Charité Universitätsmedizin Berlin, Campus Mitte, Germany.

Claudia Hindinger (C)

Department of Psychiatry, Psychotherapy and Psychosomatics, Brandenburg Medical School Theodor Fontane, Campus Neuruppin, 16816 Germany.

Johannes Rentzsch (J)

Department of Psychiatry, Psychotherapy and Psychosomatics, Brandenburg Medical School Theodor Fontane, Campus Neuruppin, 16816 Germany; Department of Psychiatry and Psychotherapy, Charité Universitätsmedizin Berlin, Campus Mitte, Germany.

Walter de Millas (W)

Department of Psychiatry, Vivantes Wenckebach-Klinikum Berlin, Germany.

Maria-Christiane Jockers-Scherübl (MC)

Department of Psychiatry, Oberhavel Kliniken, Henningsdorf, Germany.

Peter Bräunig (P)

Department of Psychiatry, Vivantes Humboldt-Klinikum Berlin, Germany.

Mazda Adli (M)

Department of Psychiatry and Psychotherapy, Charité Universitätsmedizin Berlin, Campus Mitte, Germany; Department of Psychiatry and Psychotherapy, Fliedner Klinik Berlin, Germany.

Roland Ricken (R)

Department of Psychiatry and Psychotherapy, Charité Universitätsmedizin Berlin, Campus Mitte, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH